SeaStar Medical is trading at $3.49, up 6.39%, with no new company-specific announcement dated August 10, 2026 identified.
- Second-quarter results are scheduled after the close on August 12, 2026.
- An acute kidney injury webinar is scheduled for August 11, 2026, potentially supporting investor interest, though no direct connection to the move is confirmed.
- Friday’s gain followed weaker U.S. employment data and increased rate-cut expectations; August 10 market futures are mixed.